CVE-2022-23769: Remote code execution vulnerability due to insufficient user privilege verification in reverseWall-MDS
CVE-2022-23769 is a high-severity flaw (CVSS 7.5) affecting reversewall-mds. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Remote code execution vulnerability due to insufficient user privilege verification in reverseWall-MDS. Remote attackers can exploit the vulnerability such as stealing account, through remote code execution.
Why this priority
- High severity
A fixed release or distro patch exists.
Risk facts
| CVSS score | 7.5 (High) |
| Attack vector | Adjacent network |
| Attack complexity | High |
| Privileges needed | None |
| User interaction | None |
| EPSS exploit chance | 1.1% (top 34%) |
| CISA exploited list | No |
| Weakness | CWE-287 |
| Published | 2022-10-17 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2022-23769?
reversewall-mds: upgrade to 3.8_a008. Exact commands for each OS are on this page.
Is CVE-2022-23769 being exploited?
CVE-2022-23769 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2022-23769 affect?
CVE-2022-23769 affects reversewall-mds. Severity is high (CVSS 7.5). Remote code execution vulnerability due to insufficient user privilege verification in reverseWall-MDS. Remote attackers can exploit the vulnerability such as stealing account, through remote code execution.
How urgent is CVE-2022-23769?
Priority 43/100. High severity